Eltrombopag
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Eltrombopag and local guidelines before prescribing.
Thrombopoietin agonist
Mechanism
Thrombopoietin receptor agonist.
Uses
Chronic ITP, aplastic anaemia, hepatitis C thrombocytopenia.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hepatotoxicity, thrombosis, cataracts, headache.
Interactions
Polyvalent cations reduce absorption (separate by 4 hours).
Contraindications and cautions
Liver disease caution
Monitoring
Platelets, LFT
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in hepatic impairment and East Asian ancestry
Overdose and reversal
Supportive
Special advice
Monitor LFT and platelets; do not normalise platelet count.
More from the textbook: uses, cautions and other points
- Eltrombopag - liver toxicity (LFTs), must be taken apart from calcium, dairy, antacids and iron (they bind it); cataracts.
Haematology: Anatomy Physiology and Pharmacology - Eltrombopag / romiplostim / avatrombopag | TPO receptor agonists - second-line ITP; aplastic anaemia (eltrombopag).
Haematology: Haemostasis and Thrombosis - Romiplostim / eltrombopag | TPO agonists for ITP; eltrombopag - liver, separate from calcium.
Haematology: Anatomy Physiology and Pharmacology - Immunosuppression - antithymocyte globulin (ATG) with ciclosporin , plus eltrombopag .
Haematology: Anaemia - ATG + ciclosporin + eltrombopag | Aplastic anaemia not suitable for transplant.
Haematology: Anaemia - Thrombopoietin receptor agonists - eltrombopag, romiplostim, avatrombopag.
Haematology: Haemostasis and Thrombosis - Growth factors: erythropoietin (kidney - anaemia of CKD), G-CSF (neutrophils - used after chemotherapy and for stem cell mobilisation), thrombopoietin (liver - TPO receptor agonists romiplostim and eltrombopag in ITP), IL-3, GM-CSF.
0231
Where it is discussed in the book
- Haematology: Anatomy Physiology and Pharmacology (2 mentions)
- Haematology: Anaemia (2 mentions)
- Haematology: Haemostasis and Thrombosis (2 mentions)
- 0231 (1 mention)